One study found that the majority of GLP-1 patients regained two-thirds of their prior weight a year after discontinuing their medication
In 2025, researchers at the Cleveland Clinic provided a major piece of the puzzle: the Neurobeachin (NBEA) gene
We conducted a comprehensive literature search across databases, including PubMed and Web of Science, compiling data from clinical trials, case reports, and basic research studies published up to 2025, with a focus on the efficacy, safety, and mechanism of action of drugs such as liraglutide, semaglutide, and tirzepatide in patients with MC4R deficiency
Why GLP-1 Drugs Alone Arent Enough for Sustainable Weight Loss Share Introduction GLP-1 medications like semaglutide and liraglutide have changed the conversation around weight loss
We combine clinically proven medications with individual counseling on lifestyle, nutrition, diet, and exercise
This was repeated for three drinks over one hour